XNK Therapeutics appoints Dr. Peter Hovstadius as CMO
/PRNewswire/ -- XNK Therapeutics AB ("XNK") today announced the appointment of Dr. Peter Hovstadius as Chief Medical Officer (CMO), effective immediately. Dr....
Uppsala Lan Johan Liwing Johan Aschan Peter Hovstadius Uppsala University Clinical Development Of The Novel Cyanoguanidine
Source: prnewswire.com